JOHNSON JENNIFER M 4

What Happened
Jennifer M. Johnson, listed as a director, was reported to have acquired 499 shares of Thermo Fisher Scientific (TMO) on May 20, 2026 as an award/grant (transaction code A). The filing shows an acquisition price of $0.00 per share (total reported value $0), indicating these shares were received as compensation or a grant rather than purchased.

Key Details

• Transaction date: May 20, 2026; Filing date: May 22, 2026 (timely filing).
• Transaction type: Award/Grant (Code A).
• Shares acquired: 499; Price per share reported: $0.00; Total reported value: $0.
• Shares owned after transaction: Not specified in the filing.
• Notable footnote: The filing states the reporting person is Chief Executive Officer and a Director of Franklin Resources, Inc. (Franklin Templeton). Franklin Templeton subsidiaries manage investment products and client accounts that hold the issuer’s securities in the ordinary course of business, and the reporting person disclaims beneficial ownership of such securities.

Context
An award/grant is an acquisition but typically reflects compensation or an institutional allocation rather than an open-market purchase — it should not be interpreted as a personal buy/sell market signal. The disclaimer about Franklin Templeton suggests this filing involves institutional-managed holdings; the reporting person disclaims beneficial ownership, meaning the reported shares may be held by Franklin Templeton accounts rather than personally by the individual.